Cytosorbents Announces 1-for-20 Reverse Stock Split, Effective September 8
Benzinga Newsdesk 1 month ago
Stock SplitNewsHealth CareGeneral
Reverse Stock Split Previously Approved by Shareholders; Intended to Support Compliance with Nasdaq's $1.00 Minimum Bid Price RequirementExpected to Become Effective and Trade on Split-Adjusted Basis at the Market
- Reverse Stock Split Previously Approved by Shareholders; Intended to Support Compliance with Nasdaq's $1.00 Minimum Bid Price Requirement
- Expected to Become Effective and Trade on Split-Adjusted Basis at the Market Open on September 8, 2026